Grants: Ophthalmic Genetics

​

An IPSC Cell-Based Model of Macular Degeneration for Drug Discovery

  • Wahlin Karl, Ph.D. 
  • California Institute for Regenerative Medicine

Complement Factor H Mutant Pluripotent Stem Cells to Model Early Onset Macular Degeneration and their Application in Drug Discovery

  • Wahlin Karl, Ph.D. 
  • BrightFocus Foundation

Microenvironment Based Optimization of Retinal Induction Using Crispr-Cas9 Reporter Pluripotent Stem Cells as an Expandable Source of Retinal Progenitors and Photoreceptors

  • Wahlin Karl, Ph.D. 
  • California Institute for Regenerative Medicine

Modeling Photoreceptor Development and Disease Using Human Pluripotent Stem Cells

  • Wahlin Karl, Ph.D. 
  • NIH

Show additional content areas below